We are live on ! Find out more
ENZ

Enzo Biochem, Inc.

Delisted

ENZ was delisted on the 17th of April, 2025.

86 hedge funds and large institutions have $59.9M invested in Enzo Biochem, Inc. in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $78K | Put options by funds: $18K

5% less capital invested

Capital invested by funds: $62.9M → $59.9M (-$2.96M)

4% less funds holding

Funds holding: 9086 (-4)

13% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 30

17% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 18

Holders
86
Holders Change
-4
Holders Change %
-4.44%
% of All Funds
2.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
26
Reduced
30
Closed
18
Calls
$78K
Puts
$18K
Net Calls
+$60K
Net Calls Change
+$15K
Name Holding Trade Value Shares
Change
Change in
Stake
GC
101
Globeflex Capital
California
-$1K -179 Closed
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
+$8 +3 New

ENZ Hedge Fund Activity: Q2 2015 in Review

86 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2015, worth a combined $59.9M — down 4.7% from $62.9M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of ENZ and 15 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 26 added.

The largest buyer was Wellington Management Group, adding an estimated $1.91M. The largest seller was THB Asset Management, exiting entirely with an estimated $3.11M sold.

  • 86 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2015, down from 90 in Q1 2015.
  • Funds reported $59.9M of Enzo Biochem, Inc. stock for Q2 2015, down 4.7% quarter-over-quarter.
  • 15 funds opened new Enzo Biochem, Inc. positions in Q2 2015 and 18 closed out, a net change of -3 holders.
  • The largest Enzo Biochem, Inc. buyer in Q2 2015 was Wellington Management Group, an estimated $1.91M added.
  • The largest Enzo Biochem, Inc. seller in Q2 2015 was THB Asset Management, an estimated $3.11M sold.

Based on aggregated 13F filings for Q2 2015.